Meetings at which this manuscript was presented: International Psycho-Oncology Society, 15th World Congress of Psycho-Oncology, Poster session, 6–8 November 2013, Rotterdam, the Netherlands
Large cohort studies are needed taking into account cancer-related, personal, biological, psychobehavioral, and lifestyle-related factors, to guide future research to improve treatment and supportive care. We aimed to evaluate the feasibility of a comprehensive baseline assessment of a cohort study evaluating the course of quality of life (QoL).
Newly diagnosed head and neck cancer (HNC) patients were asked to participate. Assessments consisted of questionnaires (635 items), a home visit (including a psychiatric interview, physical tests, and blood and saliva collection), and tissue collection. Representativeness of the study sample was evaluated by comparing demographics, clinical factors, depression, anxiety, and QoL between responders and non-responders. Feasibility was evaluated covering the number of questions, time investment, intimacy, and physical burden.
During the inclusion period (4 months), 15 out of 26 (60 %) patients agreed to participate. Less women participated, 13 % in responders group versus 63 % in non-responders group (p = 0.008). No other differences were found between responders and non-responders. Responders completed more than 95 % of the questionnaires’ items and rated the number of questions, time investment and intimacy as feasible, and the physical and psychological burden as low. It took on average 3 h to complete the questionnaires and 1.5 h for the home visit.
This study reveals that a comprehensive assessment including various questionnaires, physical measurements, and biological assessments is feasible according to patients with newly diagnosed HNC. A large prospective cohort study has started aiming to include 739 HNC patients and their informal caregivers in the Netherlands.
Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, et al (2012) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer
Braakhuis BJ, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50(7):670–5
Urba S, Gatz J, Shen W, Hossain A, Winfree K, Koustenis A et al (2012) Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy. Oral Oncol 48(8):723–729 PubMedCrossRef
Borghgraef K, Delaere P, Van den BW, Feenstra L (1997) Quality of life in head and neck cancer patients. Acta Otorhinolaryngol Belg 51(2):69–72 PubMed
Verdonck-de LI, van Nieuwenhuizen A, Leemans CR (2012) The value of quality-of-life questionnaires in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 20(2):142–147 CrossRef
Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ et al (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33(8):879–885 PubMedCrossRef
- A comprehensive assessment protocol including patient reported outcomes, physical tests, and biological sampling in newly diagnosed patients with head and neck cancer: is it feasible?
Annette J. van Nieuwenhuizen
Laurien M. Buffart
Jan H. Smit
Ruud H. Brakenhoff
Boudewijn J. M. Braakhuis
Remco de Bree
C. René Leemans
Irma M. Verdonck-de Leeuw
- Springer Berlin Heidelberg
Neu im Fachgebiet Onkologie
Mail Icon II